Roundup

Life Sciences Cases To Watch 2024: A Midyear Report

By Mark Payne · July 30, 2024, 10:55 PM EDT

From the U.S. Supreme Court down to the federal district courts, judges and lawmakers are grappling with questions crucial to the life sciences industry. ...

To view the full article, register now.

Case Information

Case Title

In Re: National Prescription Opiate Litigation

Case Number

1:17-md-02804

Court

Ohio Northern

Nature of Suit

P.I.: Other

Date Filed

November 04, 2022


Case Title

Edwards Lifesciences Corporation v. Meril Life Sciences Pvt. Ltd.

Case Number

22-1877

Court

Appellate - Federal Circuit

Nature of Suit

830 Patent Infringement (Fed. Qst.)

Date Filed

June 07, 2022


Case Title

Natl Infusion Center v. Becerra

Case Number

24-50180

Court

Appellate - 5th Circuit

Nature of Suit

2440 Other Civil Rights

Date Filed

March 14, 2024


Case Title

AstraZeneca Pharmaceuticals LP, et al v. Secretary United States Department of Health and H, et al

Case Number

24-1819

Court

Appellate - 3rd Circuit

Nature of Suit

2899 APA Review/Appeal

Date Filed

May 02, 2024


Case Title

Bristol Myers Squibb Co v. Secretary United States Department of HHS, et al

Case Number

24-1820

Court

Appellate - 3rd Circuit

Nature of Suit

2440 Other Civil Rights

Date Filed

May 06, 2024


Case Title

Janssen Pharmaceuticals Inc v. Secretary United States Department of HHS, et al

Case Number

24-1821

Court

Appellate - 3rd Circuit

Nature of Suit

2440 Other Civil Rights

Date Filed

May 06, 2024